Annual SG&A
$11.61 M
+$3.08 M+36.10%
31 December 2023
Summary:
Oncolytics Biotech annual selling, general & administrative expenses is currently $11.61 million, with the most recent change of +$3.08 million (+36.10%) on 31 December 2023. During the last 3 years, it has risen by +$2.27 million (+24.33%). ONCY annual SG&A is now at all-time high.ONCY Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.28 M
-$181.10 K-7.37%
30 September 2024
Summary:
Oncolytics Biotech quarterly selling, general & administrative expenses is currently $2.28 million, with the most recent change of -$181.10 thousand (-7.37%) on 30 September 2024. Over the past year, it has dropped by -$1.63 million (-41.69%). ONCY quarterly SG&A is now -41.69% below its all-time high of $3.90 million, reached on 30 September 2023.ONCY Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.35 B
-$22.44 M-1.68%
30 September 2024
Summary:
Oncolytics Biotech TTM selling, general & administrative expenses is currently -$1.35 billion, with the most recent change of -$22.44 million (-1.68%) on 30 September 2024. Over the past year, it has dropped by -$1.37 billion (-11922.31%). ONCY TTM SG&A is now -233034.69% below its all-time high of $11.62 million, reached on 31 December 2023.ONCY TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCY Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.1% | -41.7% | -10000.0% |
| 3 y3 years | +24.3% | -0.4% | -10000.0% |
| 5 y5 years | - | - | - |
ONCY Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +36.1% | -41.7% | +30.0% | -13.6% | at low |
| 5 y | 5 years | at high | +36.1% | -41.7% | +30.0% | -41.7% | at low |
| alltime | all time | at high | >+9999.0% | -41.7% | +185.2% | <-9999.0% | at low |
Oncolytics Biotech Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.28 M(-7.4%) | $9.73 M(-14.3%) |
| June 2024 | - | $2.46 M(+11.1%) | $11.35 M(-1.0%) |
| Mar 2024 | - | $2.21 M(-20.5%) | $11.47 M(-1.3%) |
| Dec 2023 | $11.61 M(+36.1%) | $2.78 M(-28.7%) | $11.62 M(+1.4%) |
| Sept 2023 | - | $3.90 M(+51.8%) | $11.46 M(+23.1%) |
| June 2023 | - | $2.57 M(+8.9%) | $9.31 M(+4.8%) |
| Mar 2023 | - | $2.36 M(-10.1%) | $8.88 M(+3.6%) |
| Dec 2022 | $8.53 M(-16.8%) | $2.63 M(+50.1%) | $8.58 M(-0.1%) |
| Sept 2022 | - | $1.75 M(-18.5%) | $8.59 M(-5.9%) |
| June 2022 | - | $2.15 M(+4.6%) | $9.12 M(+30.8%) |
| Mar 2022 | - | $2.05 M(-22.1%) | $6.97 M(+41.7%) |
| Dec 2021 | $10.26 M(+9.8%) | $2.64 M(+15.5%) | $4.92 M(+115.5%) |
| Sept 2021 | - | $2.28 M(+124.0%) | $2.28 M(-29.4%) |
| Dec 2020 | $9.34 M(+2400.6%) | - | - |
| Sept 2011 | - | $1.02 M(-5.0%) | $3.24 M(-6.9%) |
| June 2011 | - | $1.07 M(-6.1%) | $3.47 M(-0.8%) |
| Mar 2011 | - | $1.14 M(-9.2%) | $3.50 M(+217.6%) |
| Sept 2010 | - | $1.26 M(+14.2%) | $1.10 M(+110.9%) |
| June 2010 | - | $1.10 M(+18.9%) | $522.90 K(+92.7%) |
| Mar 2010 | - | $926.70 K(-142.4%) | $271.40 K(+83.3%) |
| Dec 2009 | $373.50 K(+519.4%) | -$2.18 M(-421.9%) | $148.10 K(-143.7%) |
| Sept 2009 | - | $678.20 K(-20.2%) | -$338.70 K(+119.1%) |
| June 2009 | - | $849.90 K(+5.8%) | -$154.60 K(-148.3%) |
| Mar 2009 | - | $803.40 K(-130.1%) | $319.80 K(-47.9%) |
| Dec 2008 | $60.30 K(-98.6%) | -$2.67 M(-409.7%) | $614.40 K(-87.7%) |
| Sept 2008 | - | $862.30 K(-34.9%) | $4.99 M(+1.0%) |
| June 2008 | - | $1.32 M(+20.6%) | $4.94 M(+7.5%) |
| Mar 2008 | - | $1.10 M(-35.7%) | $4.60 M(+7.1%) |
| Dec 2007 | $4.23 M | $1.71 M(+109.5%) | $4.29 M(+25.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2007 | - | $815.00 K(-16.8%) | $3.42 M(+3.0%) |
| June 2007 | - | $979.40 K(+23.6%) | $3.32 M(-0.8%) |
| Mar 2007 | - | $792.10 K(-5.0%) | $3.35 M(+29.4%) |
| Dec 2006 | $3.56 M(+36.8%) | $833.60 K(+16.7%) | $2.58 M(-1.0%) |
| Sept 2006 | - | $714.50 K(-28.9%) | $2.61 M(+9.4%) |
| June 2006 | - | $1.00 M(+3050.2%) | $2.39 M(+18.9%) |
| Mar 2006 | - | $31.90 K(-96.3%) | $2.01 M(-22.9%) |
| Dec 2005 | $2.60 M(-38.3%) | $860.40 K(+75.4%) | $2.60 M(-19.5%) |
| Sept 2005 | - | $490.50 K(-21.5%) | $3.23 M(-3.0%) |
| June 2005 | - | $625.00 K(-0.5%) | $3.34 M(-14.0%) |
| Mar 2005 | - | $627.90 K(-57.9%) | $3.88 M(+2.5%) |
| Dec 2004 | $4.21 M(+99.4%) | $1.49 M(+151.7%) | $3.78 M(+35.5%) |
| Sept 2004 | - | $592.10 K(-49.2%) | $2.79 M(-4.3%) |
| June 2004 | - | $1.17 M(+118.8%) | $2.92 M(+26.2%) |
| Mar 2004 | - | $532.80 K(+6.7%) | $2.31 M(+8.8%) |
| Dec 2003 | $2.11 M(+57.8%) | $499.20 K(-30.5%) | $2.12 M(+8.7%) |
| Sept 2003 | - | $718.00 K(+28.2%) | $1.95 M(+28.5%) |
| June 2003 | - | $560.10 K(+62.1%) | $1.52 M(+12.8%) |
| Mar 2003 | - | $345.60 K(+5.0%) | $1.35 M(+3.0%) |
| Dec 2002 | $1.34 M(+33.3%) | $329.10 K(+15.5%) | $1.31 M(+33.6%) |
| Sept 2002 | - | $284.90 K(-26.4%) | $979.00 K(+41.0%) |
| June 2002 | - | $387.20 K(+26.2%) | $694.10 K(+126.2%) |
| Mar 2002 | - | $306.90 K(-1.4%) | $306.90 K(-56.6%) |
| Dec 2001 | $1.00 M(+40.6%) | - | - |
| Dec 2000 | $714.30 K(+1092.5%) | $311.30 K(+71.7%) | $707.80 K(+78.5%) |
| Sept 2000 | - | $181.30 K(+10.2%) | $396.50 K(+84.2%) |
| June 2000 | - | $164.50 K(+224.5%) | $215.20 K(+324.5%) |
| Mar 2000 | - | $50.70 K | $50.70 K |
| Dec 1999 | $59.90 K | - | - |
FAQ
- What is Oncolytics Biotech annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Oncolytics Biotech?
- What is Oncolytics Biotech annual SG&A year-on-year change?
- What is Oncolytics Biotech quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Oncolytics Biotech?
- What is Oncolytics Biotech quarterly SG&A year-on-year change?
- What is Oncolytics Biotech TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Oncolytics Biotech?
- What is Oncolytics Biotech TTM SG&A year-on-year change?
What is Oncolytics Biotech annual selling, general & administrative expenses?
The current annual SG&A of ONCY is $11.61 M
What is the all time high annual SG&A for Oncolytics Biotech?
Oncolytics Biotech all-time high annual selling, general & administrative expenses is $11.61 M
What is Oncolytics Biotech annual SG&A year-on-year change?
Over the past year, ONCY annual selling, general & administrative expenses has changed by +$3.08 M (+36.10%)
What is Oncolytics Biotech quarterly selling, general & administrative expenses?
The current quarterly SG&A of ONCY is $2.28 M
What is the all time high quarterly SG&A for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly selling, general & administrative expenses is $3.90 M
What is Oncolytics Biotech quarterly SG&A year-on-year change?
Over the past year, ONCY quarterly selling, general & administrative expenses has changed by -$1.63 M (-41.69%)
What is Oncolytics Biotech TTM selling, general & administrative expenses?
The current TTM SG&A of ONCY is -$1.35 B
What is the all time high TTM SG&A for Oncolytics Biotech?
Oncolytics Biotech all-time high TTM selling, general & administrative expenses is $11.62 M
What is Oncolytics Biotech TTM SG&A year-on-year change?
Over the past year, ONCY TTM selling, general & administrative expenses has changed by -$1.37 B (-11922.31%)